Inter-Research > DAO > v154 > p1-6  
DAO
Diseases of Aquatic Organisms

via Mailchimp

DAO 154:1-6 (2023)  -  DOI: https://doi.org/10.3354/dao03726

NOTE
Isolation and identification of Streptococcus agalactiae in cage-cultured green chromide Etroplus suratensis in Kerala, India

Sneha Kalasseril Girijan1, Rahul Krishnan2, Keerthana Maniyappan1, Devika Pillai1,*

1Department of Aquatic Animal Health Management, Kerala University of Fisheries and Ocean Studies, Kochi, Kerala 682506, India
2Department of Aqualife Medicine, Chonnam National University, Yeosu, Jeonnam 61186, Republic of Korea
*Corresponding author:

ABSTRACT: Streptococcus agalactiae is one of the main aetiological agents in large-scale mortalities of tilapia, having caused major economic losses to the aquaculture industry in recent years. This study describes the isolation and identification of the bacteria from cage-cultured Etroplus suratensis that experienced moderate to severe mortalities in Kerala, India. Gram-positive, catalase-negative S. agalactiae was identified from brain, eye and liver of the fish by antigen grouping and 16S rDNA sequencing. Multiplex PCR confirmed that the isolate belonged to capsular serotype Ia. Antibiotic susceptibility tests showed that the isolate was resistant to methicillin, vancomycin, tetracycline, kanamycin, streptomycin, ampicillin, oxacillin and amikacin. Histological sections of the infected E. suratensis brain revealed infiltration of inflammatory cells, vacuolation and meningitis. This report is the first description of S. agalactiae as a primary pathogen causing mortalities in E. suratensis culture in Kerala.


KEY WORDS: Fish pathogen · Group B Streptococcus · Aquaculture · Kerala · Capsular serotyping


Full text in pdf format
Cite this article as: Girijan SK, Krishnan R, Maniyappan K, Pillai D (2023) Isolation and identification of Streptococcus agalactiae in cage-cultured green chromide Etroplus suratensis in Kerala, India. Dis Aquat Org 154:1-6. https://doi.org/10.3354/dao03726

Export citation
Share:    Facebook - - linkedIn

Next article